Your browser doesn't support javascript.
loading
Women's contraceptive choice following the use of Implanon NXT: Findings from a study in Durban, South Africa.
Beesham, Ivana; Smit, Jennifer; Bosman, Shannon L; Milford, Cecilia; Panday, Mala; Beksinska, Mags.
Afiliación
  • Beesham I; MRU (MatCH Research Unit), Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of the Witwatersrand, Durban, South Africa.
  • Smit J; MRU (MatCH Research Unit), Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of the Witwatersrand, Durban, South Africa.
  • Bosman SL; MRU (MatCH Research Unit), Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of the Witwatersrand, Durban, South Africa.
  • Milford C; MRU (MatCH Research Unit), Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of the Witwatersrand, Durban, South Africa.
  • Panday M; King Dinuzulu Hospital Complex, KwaZulu-Natal Provincial Department of Health, Durban, South Africa.
  • Beksinska M; MRU (MatCH Research Unit), Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of the Witwatersrand, Durban, South Africa.
Afr J Reprod Health ; 25(1): 41-48, 2021 Feb.
Article en En | MEDLINE | ID: mdl-34077109
Implanon NXT was introduced in South Africa (SA) in 2014 to expand the contraceptive method mix. While studies have explored patterns of implant use, data on contraceptive choice following implant removal is limited. Here, we describe contraceptive choice among 120 women requesting Implanon NXT removal, between 2017 and 2018, at an urban reproductive health clinic in Durban, SA. Among women who used the implant for three years (n=91), >50% chose to reinsert Implanon NXT. Reasons for choosing to reinsert included satisfaction with the implant, the desire for a long-acting method and having had no side effects. A third of women chose not to reinsert Implanon NXT after three years due to side effects such as problematic bleeding. Most women requesting early removal of the implant switched to male condoms, injectables or oral contraceptives. Contraceptive services should provide women with contraceptive options and allow women to make informed decisions regarding contraceptive choice, in addition to providing support and managing side effects among Implanon NXT users.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Conducta de Elección / Desogestrel / Anticonceptivos Femeninos / Remoción de Dispositivos / Prioridad del Paciente / Agentes Anticonceptivos Hormonales Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Afr J Reprod Health Asunto de la revista: MEDICINA REPRODUTIVA Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Conducta de Elección / Desogestrel / Anticonceptivos Femeninos / Remoción de Dispositivos / Prioridad del Paciente / Agentes Anticonceptivos Hormonales Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Afr J Reprod Health Asunto de la revista: MEDICINA REPRODUTIVA Año: 2021 Tipo del documento: Article